Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Iyer Deepak D.

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
Mondelez International, Inc. [ MDLZ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and President AMEA
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock 51,098(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) (2) 02/20/2030 Class A Common Stock 6,990 59.04 D
Stock Options (right to buy) (3) 02/18/2031 Class A Common Stock 6,271 56.13 D
Stock Options (right to buy) (4) 02/24/2032 Class A Common Stock 8,510 64.65 D
Stock Options (right to buy) (5) 03/02/2033 Class A Common Stock 22,950 65.36 D
Explanation of Responses:
1. Total number of shares includes 7,900 deferred stock units awarded under the Issuer's Amended and Restated 2005 Performance Incentive Plan. Deferred stock units will vest on July 1, 2025.
2. Options vest in three annual installments as follows: 33% on February 20, 2021; 33% on February 20, 2022; and 34% on February 20, 2023.
3. Options vest in three annual installments as follows: 33% on February 18, 2022; 33% on February 18, 2023; and 34% on February 18, 2024.
4. Options vest in three annual installments as follows: 33% on February 24, 2023; 33% on February 24, 2024; and 34% on February 24, 2025.
5. Options vest in three annual installments as follows: 33% on March 2, 2024; 33% on March 2, 2025; and 34% on March 2, 2026.
Exhibit 24.1 Power of Attorney
/s/ Issa Yesufu, by Power of Attorney 06/08/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24.1

Know all by these presents, that the undersigned hereby constitutes and appoints
Ellen M. Smith and Issa Yesufu, signing singly, the undersigned's true and
lawful attorney-in-fact to:
(1)	prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to
the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including
amendments thereto, and any other documents necessary or appropriate to obtain
codes and
passwords enabling the undersigned to make electronic filings with the SEC of
required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of
the SEC;
(2)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive
officer and/or director of Mondelez International, Inc. (the "Company"), Forms
3, 4 and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
(3)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary
or desirable to complete and execute any such Form 3, 4 or 5, complete and
execute any
amendment or amendments thereto, and timely file such form with the SEC and any
exchange or similar authority; and
(4)	take any other action of any type whatsoever in connection with the
foregoing which, in the
opinion of such attorney-in-fact, may be of benefit to, in the best interest of,
or legally
required by, the undersigned, it being understood that the documents executed by
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney
shall be in
such form and shall contain such terms and conditions as such attorney-in-fact
may approve
in such attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform
any and every act and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully
do or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted. The
undersigned acknowledges that the foregoing attorney-in-fact, in serving in such
capacity at the request
of the undersigned, is not assuming, nor is the Company assuming, any of the
responsibilities to comply with Section 16 of the Securities Exchange Act of
This Power of Attorney is effective May 1, 2023, and revokes all prior Powers of
Attorney relating to
reporting under Section 16 of the Securities Exchange Act of 1934 of the
Company's securities and the
matters outlined above and shall remain in full force and effect until the
undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing
attorney-in-fact or in a subsequently filed instrument.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this
17th day of May, 2023.

/s/ Deepak D. Iyer
Deepak D. Iyer
Print Name